Lundbeck Logo (EUIPO, 06/19/2019)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Lundbeck was filed as Figurative mark on 06/19/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/17/2019.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Starfish #Rectangles #Several quadrilaterals juxtaposed, joined or intersecting #Quadrilaterals containing other inscriptions #Green #Blue #White, grey, silver
| Trademark form | Figurative mark |
| File reference | 018083733 |
| Application date | June 19, 2019 |
| Publication date | July 10, 2019 |
| Entry date | October 17, 2019 |
| Expiration date | June 19, 2029 |
Trademark owner
Ottiliavej 9
2500 Valby
DK
2500 Valby
DK
goods and services
5
Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP); pharmaceutical preparations and substances for the prevention and treatment of restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes
ID: 11018083733